Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

(R,S)-Equol 7-β-D-glucuronide, but not other circulating isoflavone metabolites, modulates migration and tubulogenesis in human aortic endothelial cells targeting the VEGF pathway

  • Giménez-Bastida, J. A.
  • Ávila-Gálvez, María Ángeles
  • Martínez-López, Alicia
  • García-Moreno, Diana
  • Espín de Gea, Juan Carlos
  • González-Sarrías, Antonio
Current knowledge indicates that the consumption of isoflavone-rich foodstuffs can have a beneficial impact on cardiovascular health. To what extent these isoflavones act as the main actors of that benefit is less clear. Genistein (GEN), daidzein (DAZ), and the DAZ-derived microbial metabolite equol (Eq) exhibit antiangiogenic effects in vitro, but their low bloodstream concentrations make it difficult to rationalize the in vivo effects. Their derived phase-II metabolites (glucuronides and sulfates) are major metabolites found in plasma, but their role as antiangiogenic molecules remains unexplored. We aimed here to first assess the anti-angiogenic activities of the main circulating isoflavone metabolites (glucuronides and sulfates) and compare them with their corresponding free forms at physiological concentrations (0.1–10 μM). The effects of the conjugated vs. free forms on tubulogenesis, cell migration, and VEGF-induced signalling were investigated in primary human aortic endothelial cells (HAECs). While (R,S)-equol 7-β-D-glucuronide (Eq 7-glur) exerted dose-dependent inhibition of tubulogenesis and endothelial migration comparable to that exerted by the free forms (GEN, DAZ, and Eq), the rest of the phase-II conjugates exhibited no significant effects. The underlying molecular mechanisms were independent of the bFGF but related to the modulation of the VEGF pathway. Besides, the observed dissimilar cellular metabolism (conjugation/deconjugation) places the phase-II metabolites as precursors of the free forms; however, the question of whether this metabolism impacts their biological activity requires additional studies. These new insights suggest that isoflavones and their circulating metabolites, including Eq 7-glur, may be involved in cardiovascular health (e.g., targeting angiogenesis), J. A. G.-B. was supported by a Standard European Marie Curie Individual Fellowship from the European Commission. D. G.-M. was supported by a Miguel Servet contract (AES 2021; CP21/00028) funded by the Institute Carlos III and by “ERDF a way of making Europe”. This work has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No. 838991. This work was supported by the Ramón y Cajal grant (RyC2021-032111-I) and by the grants CNS2022-135253 and TED2021-130962B-C22 funded by the MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR” program, grants PID2022-136915NA-I00 and PID2022-136419OB-I00 funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” by the European Union, and the grant 22030/PI/22 funded by the Programa Regional de Fomento de la Investigación Científica y Técnica (Plan de Actuación 2022) de la Fundación Séneca-Agencia de Ciencia y Tecnología de la Región de Murcia, Spain, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metabolic Profiling of a Mediterranean-Inspired (Poly)phenol-Rich Mixture in the Brain: Perfusion Effect and In Vitro Blood-Brain Barrier Transport Validation

  • Ávila-Gálvez, María Ángeles
  • Garay-Mayol, Beatriz
  • Marín, Alicia
  • Brito, María Alexandra
  • Giménez-Bastida, J. A.
  • Espín de Gea, Juan Carlos
  • González-Sarrías, Antonio
A Mediterranean diet rich in (poly)phenols has been linked to neuroprotection, but its effects likely depend on the ability of phenolic metabolites to cross the blood-brain barrier (BBB). This study evaluated the kinetics plasma and brain distribution of phenolic metabolites in Sprague-Dawley rats following oral administration of a polyphenol-rich extract mixture from Mediterranean foods (pomegranate, lemon, orange, grape, and olive). UPLC-ESI-QTOF analyses revealed 39 phenolic-derived metabolites in plasma, of which 20 were in nonperfused (NPB) and 19 in perfused brains (PB), including hydroxytyrosol and tyrosol sulfates, ellagic acid, dihydrocaffeic acid, and derived metabolites. Kinetic data showed substantially higher plasma metabolite concentrations than the brain, with slightly higher levels in NPB. The BBB transport efficiency of phenolic metabolites was validated in vitro using human brain microvascular endothelial cells (HBMECs), showing improved transport when tested as mixtures. These findings confirm that circulating phenolic metabolites from Mediterranean foods can reach brain tissues, contributing to preventing neurodegenerative diseases., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Buckwheat Flavonoids Modulate Inflammation in RAW 264.7 Macrophages at Physiologically Relevant Concentrations via the LPS/COX-2 Pathway

  • López-Cánovas, Diego José
  • Vico-Padilla, Antonio
  • Zielinska, Danuta
  • Poveda-Lora, Sabrina
  • Navarro-Orcajada, Silvia
  • López-Martínez, David
  • García-Moreno, Diana
  • Ávila-Gálvez, María Ángeles
  • Garay-Mayol, Beatriz
  • Yuste, Jose E.
  • Vallejo, Fernando
  • Espín de Gea, Juan Carlos
  • González-Sarrías, Antonio
  • Zielinski, Henryk
  • Giménez-Bastida, J. A.
Buckwheat (BW) is recognized as a functional food with antioxidant and anti-inflammatory properties. BW (poly)phenols are important bioactive compounds associated with these benefits, although their therapeutic role remains elusive. We used a multidisciplinary approach to identify the bioactive flavonoids of BW and their molecular mechanisms. Physiologically relevant concentrations of luteolin (Lute), quercetin (Quer), apigenin (Api), and kaempferol (Kaem) were effective in reducing prostaglandin (PG)E2 and PGD2 biosynthesis in LPS-activated macrophages by acting at distinct branch points of the LPS/COX-2 pathway. Lute, Api, and Kaem reduced COX-2 levels, whereas Quer exerted the opposite effect. Lute and Kaem inhibited Ikkβ phosphorylation, while TLR4 was identified as a flavonoid's target. PGE2 and PGD2 reductions were independent of COX-2 modulation and correlated with hematopoietic prostaglandin D synthase (hPGDS) inhibition (exerted by Lute and Quer). These findings offer a new perspective on the LPS/COX-2 pathway as a target of BW-derived products to address inflammation-related diseases., This project was supported by the Ramón y Cajal grant (RyC2021-032111-I) and the CNS2022-135253 grant funded by the MICIU/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR” program. It was also supported by the grants PID2022-136915NA-I00 and PID2022-136419OB-I00 funded by MICIU/AEI/10.13039/501100011033 and by “ERDF/UE”, the grant 202570E105 (CSIC, Spain), and the Interprofessional Lemon and Grapefruit Association (AILIMPO) (Murcia, Spain). It was also funded by the grant 22030/PI/22 funded by the Programa Regional de Fomento de la Investigación Cientı́fica y Técnica (Plan de Actuación 2022) and by the grant 23023/GERM/25 funded by the program Ayudas a los Grupos y Unidades de Excelencia Cientı́fica de la Región de Murcia de la Fundación Séneca-Agencia de Ciencia y Tecnologı́a de la Región de Murcia (Spain). It was also funded by research funds from the Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences and the University of Warmia Mazury and CSIC (2025ICT020). Diana Garcı́a-Moreno was supported by the Institute of Health Carlos III through the Miguel Servet program (CP21/00028) cofunded by the European Union. David López-Martı́nez was supported by the grant for Requalification in the Spanish University System from the 2021–2023 period Margarita Salas (137/MSJD/22), funded by the “European Union NextGenerationEU/PRTR” program. Beatriz Garay-Mayol was supported by the fellowship 22777/FPI/24 funded by Fundación Séneca (Región de Murcia). Antonio Vico-Padilla was supported by the grant PREP2022-000378 funded by MICIU/AEI/10.13039/501100011033 and by ESF+. Sabrina Poveda-Lora was supported by a CSIC-funded JAE-intro fellowship (JAEINT_24_02070)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biotics: The Food Ingredients Supporting the Intestinal Microbiota and Immune System in Psoriasis

  • De Biasi, Julien
  • Giménez-Bastida, J. A.
  • Krupa-Kozak, Urszula
Psoriasis is a chronic immune-mediated inflammatory skin disease affecting 4 million new individuals worldwide each year. Although the etiology of psoriasis is not fully understood, genetic factors play a key role in conjunction with systemic inflammation and gut microbiota dysbiosis. Current methods of psoriasis treatment, while effective, may cause adverse reactions. Biotics (pre-, pro-, syn-, and postbiotics) are generally recognized as safe, have a good reputation, and have confirmed beneficial health effects. Considering the growing awareness of the impact of diet and lifestyle on health among individuals with psoriasis, the recognition of biotics as a potential source of health benefits with minimal constraints even during therapy has become more relevant. In this review, we highlight the therapeutic potential and beneficial effects of biotics in inflammatory skin diseases involving dysbiosis and screen the scientific data concerning recent randomized controlled trials that specifically assessed the use of biotics in psoriasis to understand the progress achieved to date. Most studies matching our screening criteria used lactic acid bacteria along with oligosaccharides as prebiotics. Probiotics have shown promising results in suppressing inflammatory pathways and alleviating the symptoms of psoriasis by modulating the gut microbiota. After several weeks of intervention, patients showed microbiome changes along with reduced levels of inflammatory biomarkers and psoriasis severity. Overall, biotics appear to be good candidates for improving the quality of life in patients with psoriasis; however, more randomized controlled trials with more rigid protocols and rigorously reported results are needed to properly assess their potential., This work was supported by the National Science Centre, Poland, through project OPUS 23 (project number 2022/45/B/NZ9/03004); by MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR (grants CNS2022-135253 and RyC2021-032111-I); and by MCIU/AEI/10.13039/501100011033 and ERDF/EU (grant PID2022-136915NA-I00), Peer reviewed